|
Vol. 12.13 – 5 April, 2023
|
|
|
|
|
|
Using genetically engineered and carcinogen-induced mouse models of intestinal neoplasia, scientists observed that impaired differentiation was a conserved event preceding cancer development. [Science Advances]
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
The sialylated cancer IgG (SIA-cIgG)/c-Met/SOX2/SIA-cIgG signaling loop was highly active in stem-like cells from many epithelial cancers and was crucial for cancer stemness in vitro and in vivo.
[Cancer Research]
|
|
|
|
|
Researchers observed that the expression of thymocyte-expressed, positive selection-associated 1 (Tespa1) was markedly increased in hematopoietic stem cells after stress exposure. [Leukemia]
|
|
|
|
|
Scientists described a unique translation regulatory axis enacted by reduced expression of miR-183 in breast CSCs, which they showed targeted the eIF2Bδ subunit of guanine nucleotide exchange factor eIF2B.
[Proceedings Of The National Academy Of Sciences Of The United States Of America]
|
|
|
|
|
Investigators developed a thiol-Michael addition injectable hydrogel further to capture glioblastoma/glioblastoma stem-like cells through CXCL12-mediated chemotaxis.
[Advanced Healthcare Materials]
|
|
|
|
|
Researchers showed that post-oncolytic HSV (oHSV) virotherapy-activated AKT signaling results in an enrichment of glioblastoma stem-like cell signatures in glioma. [Molecular Therapy Oncolytics]
|
|
|
|
|
Investigators evaluated novel regulators of stem cell factor expression to identify novel therapeutic strategies that could target liver CSCs.
[International Journal Of Oncology]
|
|
|
|
|
A soft agar colony formation assay using polymerase chain reaction method was applied to evaluate tumorigencitiy of cells in cellular therapy products.
[Scientific Reports]
|
|
|
|
|
The authors established a novel approach to capture and cultivate circulating tumor cells (CTCs) using a microfilter device. Whole blood was filtered to isolate CTCs and cells captured on the microfilter were cultured in place. [Oncology Reports]
|
|
|
|
|
|
Scientists summarize the characteristic features and functional mechanisms of CSC-derived exosomes/mesenchymal stem cell exosomes/cancer-associated fibroblast exosomes and their mutual impact on cancer progression and therapy resistance. [Biochimie]
|
|
|
|
|
|
Merck announced that the US FDA has granted full approval to KEYTRUDA for the treatment of adult and pediatric patients with unresectable or metastatic MSI-H or dMMR solid tumors that have progressed following prior treatment and who have no satisfactory alternative treatment options. [Merck]
|
|
|
|
|
|
April 25 – 26, 2023 Boston, Massachusetts, United States
|
|
|
|
|
|
|
University of Southern California – Los Angeles, California, United States
|
|
|
|
|
University of Texas Health Science Center – San Antonio, Texas, United States
|
|
|
|
|
Baylor College of Medicine – Houston, Texas, United States
|
|
|
|
|
University of Pennsylvania – Philadelphia, Pennsylvania, United States
|
|
|
|
|
Columbia University – New York, New York, United States
|
|
|
|
|